Cargando…
Macrophage-Biomimetic Nanoparticles Ameliorate Ulcerative Colitis through Reducing Inflammatory Factors Expression
BACKGROUND AND AIMS: Inflammatory mediator S100A9 is dramatically elevated in ulcerative colitis and correlates with disease severity. S100A9 is a potential molecule to target for the treatment of colitis, but to date, there is no effective targeting method. The aim of this study was to develop a sa...
Autores principales: | Li, Zhengshuo, Zhang, Xiaoyue, Liu, Can, Peng, Qiu, Wu, Yangge, Wen, Yuqing, Zheng, Run, Yan, Qun, Ma, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274947/ https://www.ncbi.nlm.nih.gov/pubmed/34724662 http://dx.doi.org/10.1159/000519363 |
Ejemplares similares
-
Amelioration of ulcerative colitis via inflammatory regulation by macrophage-biomimetic nanomedicine
por: Sun, Tianlei, et al.
Publicado: (2020) -
Deficiency of Lactoferrin aggravates lipopolysaccharide-induced acute inflammation via recruitment macrophage in mice
por: Liu, Can, et al.
Publicado: (2022) -
Epstein–Barr virus microRNA miR-BART2-5p accelerates nasopharyngeal carcinoma metastasis by suppressing RNase Ⅲ endonuclease DICER1
por: Wu, Yangge, et al.
Publicado: (2023) -
N6-methyladenosine regulates ATM expression and downstream signaling
por: Zhang, Xiaoyue, et al.
Publicado: (2021) -
Lactoferrin is required for early B cell development in C57BL/6 mice
por: Wei, Lingyu, et al.
Publicado: (2021)